Synergistic cardioprotective effects of TIL and syringin in diabetic cardiomyopathy through the interaction between the TLR4/NF-κB/NLRP3 and PGC1α/SIRT3 pathways have also been documented. This evidence concerns the gene TLR4 and diabetic cardiomyopathy.